Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SeaStar Medical Holding Corp ICU

Healthcare Medical Devices
SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies... see more

Recent & Breaking News (NDAQ:ICU)

SeaStar Medical and Nuwellis Enter into a U.S. License and Distribution Agreement for SeaStar Medical's Selective Cytopheretic Device (SCD) for Pediatric Acute Kidney Injury (AKI)

GlobeNewswire December 29, 2022

SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development

GlobeNewswire December 2, 2022

SeaStar Medical Appoints Rick Barnett as Chairman of the Board of Directors

GlobeNewswire November 29, 2022

SeaStar Medical's Lead Product Candidate, the Selective Cytopheretic Device (SCD), Included in Consensus Statement for Pediatric Acute Kidney Injury in First Pediatric Acute Disease Quality Initiative (ADQI) Meeting

GlobeNewswire November 7, 2022

SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children

GlobeNewswire November 3, 2022

SeaStar Medical (NASDAQ: ICU) Commences Trading on Nasdaq Capital Market and Outlines Corporate Strategy and Near-Term Catalysts

GlobeNewswire October 31, 2022

SeaStar Medical Completes Business Combination with LMF Acquisition Opportunities

GlobeNewswire October 28, 2022

LMF Acquisition Opportunities, Inc. Stockholders Approve Previously Announced Business Combination with SeaStar Medical, Inc.

GlobeNewswire October 18, 2022

LMF Acquisition Opportunities and SeaStar Medical Announce Effectiveness of Registration Statement and Special Meeting of Stockholders to be Held October 18, 2022 to Approve Business Combination

GlobeNewswire September 28, 2022

SeaStar Medical Appoints Dr. Sai Prasad Iyer, Ph.D as VP, Medical Affairs and Clinical Development

GlobeNewswire September 19, 2022

SeaStar Medical Reports First Successful Treatment of Pediatric Patient with Hemophagocytic Lymphohistiocytosis (HLH) and Multi-Organ Failure with its SCD

GlobeNewswire August 1, 2022

LMF Acquisition Opportunities, Inc. Announces Extension of Deadline to Complete Business Combination

GlobeNewswire July 29, 2022

SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury

GlobeNewswire July 20, 2022

SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality Rates among Critically Ill ICU COVID-19 Patients by Safely and Effectively Stopping Inflammation Causing Cytokine Storms

GlobeNewswire June 7, 2022

SeaStar Medical Appoints Kevin Chung, MD as Chief Medical Officer

GlobeNewswire May 24, 2022

SeaStar Medical Granted FDA Breakthrough Device Designation for a Novel Immunomodulatory Therapy for Acute Kidney Injury Patients

GlobeNewswire May 3, 2022

Skyway Capital Markets Advises SPAC on $85 Million Medical Technology Merger

Business Wire May 2, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CDK, TGNA, LMAO, MTOR, TEN

PR Newswire April 25, 2022

SeaStar Medical to Become Publicly Listed on Nasdaq via Business Combination with LMF Acquisition Opportunities, Inc.

GlobeNewswire April 22, 2022

LM Funding Reports Net Income of $11.1 Million or $2.05 Per Basic Common Share for the Second Quarter of 2021

GlobeNewswire August 16, 2021